Abstract
Toxocariasis is a zoonosis caused by Toxocara canis (dog ascarid) or Toxocara cati (cat ascarid) larvae. Humans become infected by ingesting eggs or larvae from contaminated sources (soil, water, and raw food) or via fecal–oral transmission. Ocular toxocariasis, manifesting as ocular granuloma, was first described by Wilder (1950) in patients with endophthalmitis, Coats disease, or pseudoglioma. Six years later, Nichols found second-stage larvae of T. canis in histological sections from 24 of 46 enucleated eyes with suspected retinoblastoma (Nichols 1956). Human toxocariasis comprises two clinical entities: systemic toxocariasis (also termed visceral larva migrans) and ocular toxocariasis (also termed ocular larva migrans).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn SJ, Woo SJ, Hyon JY, et al. Cataract formation associated with ocular toxocariasis. J Cataract Refract Surg. 2013;39:830–5.
Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy. 2014a;4:134–41.
Ahn SJ, Woo SJ, Jin Y, et al. Clinical features and course of ocular toxocariasis in adults. PLoS Negl Trop Dis. 2014b;8:e2938.
Alabiad CR, Albini TA, Santos CI, et al. Ocular toxocariasis in a seronegative adult. Ophthalmic Surg Lasers Imaging. 2010;2:1–3.
Biglan AW, Glickman LT, Lobes LA Jr. Serum and vitreous Toxocara antibody in nematode endophthalmitis. Am J Ophthalmol. 1979;88:898–901.
Chieffi PP, Santos SV, Queiroz ML, et al. Human toxocariasis: contribution by Brazilian researchers. Rev Inst Med Trop Sao Paulo. 2009;51:301–8.
Cortez RT, Ramirez G, Collet L, et al. Ocular parasitic diseases: a review on toxocariasis and diffuse unilateral subacute neuroretinitis. J Pediatr Ophthalmol Strabismus. 2010;28:1–9.
Fan CK, Hung CC, Du WY, et al. Seroepidemiology of Toxocara canis infection among mountain aboriginal schoolchildren living in contaminated districts in eastern Taiwan. Tropical Med Int Health. 2004;9:1312–8.
Good B, Holland CV, Taylor MR, et al. Ocular toxocariasis in schoolchildren. Clin Infect Dis. 2004;39:173–8.
Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–4.
Jin Y, Shen C, Huh S, et al. Serodiagnosis of toxocariasis by ELISA using crude antigen of Toxocara canis larvae. Korean J Parasitol. 2013;51:433–9.
Maguire AM, Green WR, Michels RG, et al. Recovery of intraocular Toxocara canis by pars plana vitrectomy. Ophthalmology. 1990;97:675–80.
Mirdha BR, Khokar SK. Ocular toxocariasis in a North Indian population. J Trop Pediatr. 2002;48:328–30.
Nichols RL. The etiology of visceral larva migrans. I. Diagnostic morphology of infective second-stage Toxocara larvae. J Parasitol. 1956;42(4 Section 1):349–62.
Olave AM, Mesa JA, Botero JH, et al. Production and evaluation of the recombinant antigen TES-30 of Toxocara canis for the immunodiagnosis of toxocariasis. Biomedica. 2016;36:39–51.
Park SP, Park I, Park HY, et al. Five cases of ocular toxocariasis confirmed by serology. Korean J Parasitol. 2000;38:267–73.
Paul M, Stefaniak J, Twardosz-Pawlik H, et al. The co-occurrence of Toxocara ocular and visceral larva migrans syndrome: a case series. Cases J. 2009;2:6881.
Rolda’n WH, Cavero YA, Espinoza YA, et al. Human toxocariasis: a seroepidemiological survey in the Amazonian city of Yurimaguas, Peru. Rev Inst Med Trop Sao Paulo. 2010;52:37–42.
Rubinsky-Elefant G, Hirata CE, Yamamoto JH, et al. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010;104:3–23.
Sharkey JA, McKay PS. Ocular toxocariasis in a patient with repeatedly negative ELISA titre to Toxocara canis. Br J Ophthalmol. 1993;77:253–4.
Shields JA. Ocular toxocariasis: a review. Surv Ophthalmol. 1984;28:361–81.
Sivaratnam D, Subrayan V, Ali NA. Transvitreal migration of a Toxocara larva resulting in a second chorioretinal granuloma. Jpn J Ophthalmol. 2008;52:416–7.
Smith H, Holland C, Taylor M, et al. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol. 2009;25:182–8.
Stensvold CR, Skov J, Moller LN, et al. Seroprevalence of human toxocariasis in Denmark. Clin Vaccine Immunol. 2009;16:1372–3.
Stewart JM, Cubillan LD, Cunningham ET Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005;25:1005–13.
Suzuki T, Joko T, Akao N, et al. Following the migration of a Toxocara larva in the retina by optical coherence tomography and fluorescein angiography. Jpn J Ophthalmol. 2005;49:159–61.
Van De N, Trung NV, Duyet le V, et al. Molecular diagnosis of an ocular toxocariasis patient in Vietnam. Korean J Parasitol. 2013;51:563–7.
de Visser L, Rothova A, de Boer JH, et al. Diagnosis of ocular toxocariasis by establishing intraocular antibody production. Am J Ophthalmol. 2008;145:369–74.
Wilder HC. Nematode endophthalmitis. Trans Am Acad Ophthalmol Otolaryngol. 1950;55:99–109.
Woodhall D, Starr MC, Montgomery SP, Jones JL, Lum F, Read RW, et al. Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology. 2012;119:1211–7.
Yokoi K, Goto H, Sakai J, et al. Clinical features of ocular toxocariasis in Japan. Ocul Immunol Inflamm. 2003;11:269–75.
Yoon DY, Woo SJ. Intravitreal administration of ranibizumab and bevacizumab for choroidal neovascularization secondary to ocular toxocariasis: a case report. Ocul Immunol Inflamm. 2018;26(4):639–41.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kim, T.W. (2020). Toxocariasis. In: Yu, H. (eds) Inflammatory and Infectious Ocular Disorders. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-13-8546-9_23
Download citation
DOI: https://doi.org/10.1007/978-981-13-8546-9_23
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8545-2
Online ISBN: 978-981-13-8546-9
eBook Packages: MedicineMedicine (R0)